Europes Pharmaceutical Industry

Download Europes Pharmaceutical Industry full books in PDF, epub, and Kindle. Read online Europes Pharmaceutical Industry ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!

Research & Development of the European Pharmaceutical Industry

Author : Arne Noack
Publisher : GRIN Verlag
ISBN 13 : 3638726703
Total Pages : 54 pages
Book Rating : 4.6/5 (387 download)

DOWNLOAD NOW!

Book Synopsis Research & Development of the European Pharmaceutical Industry by : Arne Noack

Download or read book Research & Development of the European Pharmaceutical Industry written by Arne Noack and published by GRIN Verlag. This book was released on 2007-11 with total page 54 pages. Available in PDF, EPUB and Kindle. Book excerpt: Seminar paper from the year 2003 in the subject Business economics - Operations Research, grade: A, Vrije University Brussel (Vesalius College), course: Economics, language: English, abstract: The health of their population has always been a great concern for governments of Post-War Europe. In order to achieve their goals they had to work closely together with the pharmaceutical Industry. With the phenomenon of the aging population the importance of development of new drugs is increasing. The increasingly old population of Europe creates a big market for pharmaceutical companies. The pharmaceutical Industry is a very complex sector with close links to other Industries. The chemical Industry for example is an important supplier for materials needed in the process of creating new drugs. Furthermore is the market for pharmaceuticals characterized by extremely little concentration and a huge variety of products. Globally in 1998, the 300 best-selling products held a share of less than 45% of the worlds market. The top two products held 1.3% of the market each.1 This fact creates a necessity for the companies to research new, so called "Blockbuster drugs" to succeed on this market with a high competition. The data on the various methods of drug discovery is enormous and sophisticated. In this paper the structure of the Research & Development sector of the European pharmaceutical industry will be examined, which is of increasing importance for the success of the individual companies. The specific data on the R & D section will be given a general character. Furthermore it will give a brief overview of the different regions in Europe and their individual differences. In the end, the difficulties and challenges of R & D in the pharmaceutical industry will be described and compared to other pharma markets abroad. [1 Data taken from "Combining discovery with development" by Dr. Peter Eddershaw; World pharmaceutical frontiers 2003/2004 ]

The Changing Economics of Medical Technology

Author : Institute of Medicine
Publisher : National Academies Press
ISBN 13 : 030904491X
Total Pages : 225 pages
Book Rating : 4.3/5 (9 download)

DOWNLOAD NOW!

Book Synopsis The Changing Economics of Medical Technology by : Institute of Medicine

Download or read book The Changing Economics of Medical Technology written by Institute of Medicine and published by National Academies Press. This book was released on 1991-02-01 with total page 225 pages. Available in PDF, EPUB and Kindle. Book excerpt: Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.

Euro-pharma

Author :
Publisher :
ISBN 13 :
Total Pages : 408 pages
Book Rating : 4.3/5 (91 download)

DOWNLOAD NOW!

Book Synopsis Euro-pharma by :

Download or read book Euro-pharma written by and published by . This book was released on 1994 with total page 408 pages. Available in PDF, EPUB and Kindle. Book excerpt: Lists pharmaceutical companies in Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Slovakian Republic, Spain, Sweden, Switzerland, and United Kingdom. Each company entry includes products, size, and executives. Also lists contract manufacturers, service companies, and associations.

Euro-pharma

Author :
Publisher :
ISBN 13 : 9783899477955
Total Pages : 416 pages
Book Rating : 4.4/5 (779 download)

DOWNLOAD NOW!

Book Synopsis Euro-pharma by :

Download or read book Euro-pharma written by and published by . This book was released on 2011 with total page 416 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality

Author : Mossialos, Elias
Publisher : McGraw-Hill Education (UK)
ISBN 13 : 0335214657
Total Pages : 390 pages
Book Rating : 4.3/5 (352 download)

DOWNLOAD NOW!

Book Synopsis Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality by : Mossialos, Elias

Download or read book Regulating Pharmaceuticals In Europe: Striving For Efficiency, Equity And Quality written by Mossialos, Elias and published by McGraw-Hill Education (UK). This book was released on 2004-06-01 with total page 390 pages. Available in PDF, EPUB and Kindle. Book excerpt: "This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well." Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors:Julia Abelson, Christa Altenstetter, Vittorio Berteleâ€™, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley.

The Challenges of the New EU Pharmaceutical Legislation

Author : José Luis Valverde
Publisher : IOS Press
ISBN 13 : 9781586035211
Total Pages : 154 pages
Book Rating : 4.0/5 (352 download)

DOWNLOAD NOW!

Book Synopsis The Challenges of the New EU Pharmaceutical Legislation by : José Luis Valverde

Download or read book The Challenges of the New EU Pharmaceutical Legislation written by José Luis Valverde and published by IOS Press. This book was released on 2005 with total page 154 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the domain of public policy on pharmaceuticals, protecting public health requires a dual strategy: robust regulation on the one hand and stimulation of competitiveness and innovation on the other. Regulation must be robust to ensure that only medicines meeting exact standards of safety, quality and efficacy are authorised for human and animal use. At the same time competitiveness and innovation must be stimulated. Without innovation in pharmaceuticals, the incurable diseases of today will remain incurable. Competitiveness drives innovation and innovation saves lives. Increased competitiveness of the pharmaceutical sector will not only better protect public health, but will also create high quality jobs and create growth. In this context the implementation of the G10 recommendations, particularly regarding the pricing and reimbursement of medicines by Member States, remains a considerable challenge.

Implications of Future EU Policy on the Provision of Medicines and on Actors in the European Pharmaceutical Sector

Author : Ewout Johan Marius van Ginneken
Publisher : Univerlagtuberlin
ISBN 13 : 379832235X
Total Pages : 210 pages
Book Rating : 4.7/5 (983 download)

DOWNLOAD NOW!

Book Synopsis Implications of Future EU Policy on the Provision of Medicines and on Actors in the European Pharmaceutical Sector by : Ewout Johan Marius van Ginneken

Download or read book Implications of Future EU Policy on the Provision of Medicines and on Actors in the European Pharmaceutical Sector written by Ewout Johan Marius van Ginneken and published by Univerlagtuberlin. This book was released on 2009 with total page 210 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Regulating Medicines in Europe

Author : John Abraham
Publisher : Psychology Press
ISBN 13 : 9780415208789
Total Pages : 260 pages
Book Rating : 4.2/5 (87 download)

DOWNLOAD NOW!

Book Synopsis Regulating Medicines in Europe by : John Abraham

Download or read book Regulating Medicines in Europe written by John Abraham and published by Psychology Press. This book was released on 2000 with total page 260 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book presents a critical appraisal of medicines regulation policy and exposes the influence of the pharmaceutical industry in the acceleration of drug approvals.

European Pharmaceutical Industry

Author : Susan Rance
Publisher :
ISBN 13 : 9781569655740
Total Pages : 304 pages
Book Rating : 4.6/5 (557 download)

DOWNLOAD NOW!

Book Synopsis European Pharmaceutical Industry by : Susan Rance

Download or read book European Pharmaceutical Industry written by Susan Rance and published by . This book was released on 2000 with total page 304 pages. Available in PDF, EPUB and Kindle. Book excerpt:

EU Pharmaceutical Regulation

Author : Govin Permanand
Publisher : Manchester University Press
ISBN 13 : 9780719072727
Total Pages : 272 pages
Book Rating : 4.0/5 (727 download)

DOWNLOAD NOW!

Book Synopsis EU Pharmaceutical Regulation by : Govin Permanand

Download or read book EU Pharmaceutical Regulation written by Govin Permanand and published by Manchester University Press. This book was released on 2006-09-05 with total page 272 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides an analysis of European Union pharmaceutical regulation from a policy-making perspective. The focus is on how the often conflicting agendas of the pharmaceutical industry, the EU member states, the European Commission, and consumer interests are reconciled within the context of regulatory outcomes having to serve public health, healthcare and industrial policy needs within the single market. In providing a unique perspective on how and why EU pharmaceutical policy is made, the book will be of interest to academics, students and policy-practitioners interested in EU policy-making, regulation and public policy analysis.

Completing the Internal Market for Pharmaceuticals

Author : European Federation of Pharmaceutical Industries Associations
Publisher :
ISBN 13 :
Total Pages : 82 pages
Book Rating : 4.:/5 (288 download)

DOWNLOAD NOW!

Book Synopsis Completing the Internal Market for Pharmaceuticals by : European Federation of Pharmaceutical Industries Associations

Download or read book Completing the Internal Market for Pharmaceuticals written by European Federation of Pharmaceutical Industries Associations and published by . This book was released on 1987* with total page 82 pages. Available in PDF, EPUB and Kindle. Book excerpt:

European Medicines Pricing and Reimbursement

Author : Martina Garau
Publisher : CRC Press
ISBN 13 : 1315357453
Total Pages : 207 pages
Book Rating : 4.3/5 (153 download)

DOWNLOAD NOW!

Book Synopsis European Medicines Pricing and Reimbursement by : Martina Garau

Download or read book European Medicines Pricing and Reimbursement written by Martina Garau and published by CRC Press. This book was released on 2018-04-19 with total page 207 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book is published in association with the Office of Health Economics. This book is a vital, non-technical guide illuminating recent developments within the five major European pharmaceutical markets. It clearly explains pharmaceutical regulatory policies on pricing and reimbursement, and their effects. Each chapter gives an overview of the current market, including aims, effectiveness, local markets, frameworks and politics, and then offers predictions for the next decade. Pharmaceutical executives with interests in marketing, market access and pricing will find this guide invaluable, as will health economists, government advisors and public affairs consultants. Public policy makers in areas such as the Department of Health and The Treasury and senior health service managers in hospitals will find it enlightening. It is also highly relevant to policy shapers in academia and the media, and undergraduate and postgraduate students of health economics, health policy, pharmaceutical economics and healthcare management. "This book aims not only to understand and discuss the mix of regulatory measures introduced by national policy makers in order to achieve their goals, but also to ascertain how these policies have actually shaped and influenced the characteristics and functioning of national pharmaceutical markets. In particular, each author has provided an analysis of existing pricing and reimbursement arrangements operating in their own country and an outline of policy scenarios that might emerge in the next decade." - Martina Garau and Jorge Mestre-Ferrandiz, in the Introduction.

Pharmaceutical Patents in Europe

Author : Bengt Domeij
Publisher : BRILL
ISBN 13 : 9004481478
Total Pages : 365 pages
Book Rating : 4.0/5 (44 download)

DOWNLOAD NOW!

Book Synopsis Pharmaceutical Patents in Europe by : Bengt Domeij

Download or read book Pharmaceutical Patents in Europe written by Bengt Domeij and published by BRILL. This book was released on 2021-10-25 with total page 365 pages. Available in PDF, EPUB and Kindle. Book excerpt: The pharmaceutical industry and patent legislation are inextricably linked. Pharmaceutical companies could not exist without some guarantee that they can recoup the cost of developing a new product. European patent law offers this opportunity, as it allows companies to exclude competition for a specific product for a fixed time scale. In Pharmaceutical Patents in Europe the current legal patent situation is examined by a detailed analysis of case law from the European Patent Office (EPO), the international body created with the signing of the European Patent Convention (EPC). Aspects of European patent law not primarily regulated in the EPC, for example Supplementary Protection Certificates and infringement matters, are examined in the setting provided by EC law and domestic laws of European states. This book is written for the reader who understands the main characteristics of patent law and is looking for a practitioner's text on the European pharmaceutical patent law scene. Moreover, the author's remarks can help all readers to look at the field with fresh eyes.

The Interplay of Global Standards and EU Pharmaceutical Regulation

Author : Sabrina Röttger-Wirtz
Publisher : Bloomsbury Publishing
ISBN 13 : 1509943005
Total Pages : 417 pages
Book Rating : 4.5/5 (99 download)

DOWNLOAD NOW!

Book Synopsis The Interplay of Global Standards and EU Pharmaceutical Regulation by : Sabrina Röttger-Wirtz

Download or read book The Interplay of Global Standards and EU Pharmaceutical Regulation written by Sabrina Röttger-Wirtz and published by Bloomsbury Publishing. This book was released on 2021-08-26 with total page 417 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book analyses the implementation of global pharmaceutical impact standards in the European risk regulation framework for pharmaceuticals and questions its legitimacy. Global standards increasingly shape the risk regulation law and policy in the European Union and the area of pharmaceuticals is no exception to this tendency. As this book shows, global pharmaceutical standards set by the International Council for Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), after they are adopted through the European Medicines Agency (EMA), are an important feature of the regulatory framework for pharmaceuticals in the EU. In addition to analysing the influence of these global standards in the EU legal and policy framework, the book questions the legitimacy of the Union's reliance on global standards in terms of core administrative law principles of participation, transparency and independence of expertise. It also critically examines the accountability of the European Commission and the European Medicines Agency as participants in the global standard-setting and main implementation gateway of the global pharmaceutical standards into the European Union.

EU Law of Competition and Trade in the Pharmaceutical Sector

Author : Pablo Figueroa
Publisher : Edward Elgar Publishing
ISBN 13 : 1785362615
Total Pages : 758 pages
Book Rating : 4.7/5 (853 download)

DOWNLOAD NOW!

Book Synopsis EU Law of Competition and Trade in the Pharmaceutical Sector by : Pablo Figueroa

Download or read book EU Law of Competition and Trade in the Pharmaceutical Sector written by Pablo Figueroa and published by Edward Elgar Publishing. This book was released on 2019 with total page 758 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book provides a systematic analysis of the law and practice of EU competition and trade in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-level officials at competition regulators, this work provides valuable insider knowledge on the application of law and policies to the pharmaceutical industry. The work contains extensive commentary on the legislation and the latest case law and administrative precedents in this sector, at both EU and national level, including certain significant jurisdictions (e.g., the US, China). Coverage of various key developments includes the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturers. In addition to the legal analysis, it offers vital economic and business perspectives to ensure that the reader has the full range of tools with which to prepare for cases and conduct transactions within the pharmaceutical industry.

Pharmaceuticals in the European Union

Author : European Commission. Enterprise DG.
Publisher :
ISBN 13 :
Total Pages : 46 pages
Book Rating : 4.3/5 (91 download)

DOWNLOAD NOW!

Book Synopsis Pharmaceuticals in the European Union by : European Commission. Enterprise DG.

Download or read book Pharmaceuticals in the European Union written by European Commission. Enterprise DG. and published by . This book was released on 2000 with total page 46 pages. Available in PDF, EPUB and Kindle. Book excerpt:

The European Pharmaceutical Sector and Crime Vulnerabilities

Author : Tom Vander Beken
Publisher : Maklu
ISBN 13 : 9046601064
Total Pages : 220 pages
Book Rating : 4.0/5 (466 download)

DOWNLOAD NOW!

Book Synopsis The European Pharmaceutical Sector and Crime Vulnerabilities by : Tom Vander Beken

Download or read book The European Pharmaceutical Sector and Crime Vulnerabilities written by Tom Vander Beken and published by Maklu. This book was released on 2007 with total page 220 pages. Available in PDF, EPUB and Kindle. Book excerpt: The influence of organised crime on business activities, enterprises and economic sectors is a matter of concern for many policy makers across the world. As a profit driven criminal activity, organised crime operates in an environment which is not limited to the underworld economy alone. Assessments of the threat posed by organised crime and strategic (preventive) actions to tackle this phenomenon require an understanding of the vulnerable spots in the legal economy that are or might be exploited by crime. This book is the outcome of a study known under the acronym MAVUS II (Method for and Assessment of Vulnerability of Sectors II) which addresses this issue. The study, financed under the 2005 AGIS programme of the European Commission, provides a vulnerability profile of the European pharmaceutical sector based on a new methodology to scan economic sectors for their vulnerability to (organised) crime. Both vulnerability study and methodological tool are intended as a guide for actions and initiatives to be taken by governments, law enforcement bodies and economic players.